BDL
AMGN icon

Bey-Douglas LLC’s Amgen AMGN Stock Holding History

Bey-Douglas LLC’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$331K Buy
+941
New +$335K 0.29% 39

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bey-Douglas LLC's AMGN Position: Q1 2026 in Review

Bey-Douglas LLC opened a new position in Amgen (AMGN) in Q1 2026: 941 shares worth $331K. The stake represents 0.29% of the portfolio and ranks #39 among its holdings.

3,142 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Bey-Douglas LLC held 941 shares of Amgen worth $331K as of Q1 2026.
  • Amgen was a new Bey-Douglas LLC position in Q1 2026.
  • Amgen made up 0.29% of Bey-Douglas LLC's portfolio in Q1 2026, its #39 holding.
  • 3,142 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Bey-Douglas LLC's 13F filing for Q1 2026, filed 12 May 2026.